Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 483
Selected: 0
NCT IDTitle
NCT02856997Chidamide With ICE Regimen for Relapsed/Refractory Peripheral T Cell Lymphoma
NCT02503150Trial of Antigen Pulsed Dendritic Cells (APDC) in Metastatic Colorectal Cancer
NCT03772496Diagnostic Significance of CTCs in Patients With Thyroid Nodules (Circulating Tumor Cells)
NCT06289023HA-WBRT-SIB for Brain Metastasis of Lung Cancer
NCT06405269Effect of (neo)Adjuvant Therapy on Lipids in Young Breast Cancer Patients
NCT05283616Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer
NCT06857747Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer.
NCT05762900Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients
NCT06987500A Study of PARG Inhibitor XNW29016 in Patients With Advanced Solid Tumors Who Failed Standard Treatment
NCT06921044A Study of R-mini-MCOP in the Treatment of Elderly, Previously Untreated DLBCL
NCT06993506Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
NCT05431504The Efficacy and Safety of Dalpiciclib Plus Endocrine Therapy in HR-positive / HER2-negative Advanced Breast Cancer Patients With Visceral Crisis
NCT03731442Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients
NCT05681728A Phase II Study Evaluating the Efficacy and Safety of Pembrolizumab in Combination With Chemotherapy as Neoadjuvant Therapy for Triple-negative Breast Cancer
NCT02527057Diffusion-weighted Magnetic Resonance Imaging (DW-MRI )for Early Response Assessment in Patients With Esophageal Cancer
NCT04769388Osimertinib Plus Chemotherapy vs Osimertinib in EGFRm NSCLC With Persistence Week-3 ctDNA EGFRm After 1L Osimertinib
NCT05904015The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC
NCT05816642Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma
NCT05443646Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients
NCT05986227The Sequential Combination of FOLFOX and Toripalimab for Perioperative Immuno-Oncology Therapy of HER2-negative Adenocarcinoma of the Esophagogastric Junction (Siewert I/II):
NCT05938374Preoperative Moderately Fractionated IMRT for Locally Extremity or Trunk Sarcoma (SPARE-03)
NCT06082180A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer
NCT07063888A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma
NCT05951127Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCC
NCT06610227A Study of the RNA Tumor Vaccine Targeting MICA/B in Patients With Advanced Solid Tumors
NCT05167994Preoperative IMRT With Concurrent Anlotinib for Localised Extremity or Trunk Sarcoma (SPARE-01)
NCT03708042A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer
NCT05331326A Study of RC48-ADC for the Treatment of HER2-expression Metastatic Breast Cancer With Abnormal Activation of PAM Pathway
NCT00815308Erbitux Combined With Chemo-radiotherapy in Esophageal Squamous Cell Carcinoma
NCT06540950Efficacy and Safety of Concurrent Chemoradiotherapy With Oral Vinorelbine in Patients With Non-small Cell Lung Cancer
NCT06404905Clinical Trial of BT02 in Patients With Advanced Solid Tumors
NCT07187154The Application of Symptoms Management Program Based on the Patient Reported Outcome After Esophagectomy
NCT01492556Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer
NCT06644352Right Versus Left Thoracic Surgical Approaches for Siewert II Gastroesophageal Junction Adenocarcinoma
NCT05974007Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC
NCT02861196Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer
NCT03351062Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer
NCT05411705Efficacy and Safety of rhTPO's Prophylactic Treatment of CTIT in Patients With High Risk of Cardiac Injury
NCT06577961Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients
NCT02448966Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic Esophagectomy
NCT06312982A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer
NCT03583580Accelerated Partial Breast Irradiation With IMRT in Early Breast Cancer
NCT07338396A Prospective Multicenter Study of the Association Between TCM Syndromes and EGFR-TKI Efficacy in Lung Cancer Patients
NCT04887636Baseline Study of Vaginal Microbiota in Healthy Chinses Female Population
NCT05504265Perioperative Analgesia Modes in Minimally Invasive Esophagectomy
NCT06540508Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of TACE Combined With Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma
NCT06082557A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor Patients
NCT05774171To Explore the Protective Effect of SARS-CoV-2 Vaccination on Cancer Patients Infected With SARS-CoV-2
NCT05050630Phase II Trial of Tirelizumab Combined With R2-ICE Regimen in the Treatment of rrDLBCL/HGBL
NCT06824792Optimal Standard Treatment Selection for Solid Tumor Patients by Biologically-informed Multi-agent System